Literature DB >> 10524641

Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease.

.   

Abstract

OBJECTIVES: To study the epidemiological features, clinical profile and drug utilization patterns of patients with Crohn's disease (CD).
DESIGN: A cross-sectional study of 635 Spanish patients with CD included through a stratified and proportional random sampling.
RESULTS: The mean age of the patients was 33 years (SD 11.9) (52% were women). Nine per cent of the patients had a family history of CD and 14% had a history of inflammatory bowel disease (IBD). Over half (54%) of the patients were smokers. The most frequent localization of CD was ileocolonic involvement (47%). Twelve per cent had peri-anal disease. Regarding symptom pattern, 23% of the patients had chronic active disease and 42% had experienced no relapses during the previous 12 months. Compared with the inflammatory pattern, fistulizing pattern was associated with a significantly higher proportion of patients with chronic active disease, a higher number of relapses per year, and a higher incidence of post-surgical relapses. Sixty-one per cent of the patients had complications and 35% were hospitalized. Acute relapse and bowel stricture were the most common complications. The need for hospitalization was higher in patients with fistulizing pattern. Regarding medication, 77% and 41 % of the patients were taking aminosalicylates and corticosteroids respectively, mainly on a long-term basis. Mean daily doses (MDD) were 2.2 g/day and 31.7 mg/day respectively. Twenty-one per cent had received immunosuppressors with a MDD of 1.6 mg/kg/day. Fifteen per cent of the patients had received metronidazole or ciprofloxacin while 5% were taking anti-diarrhoeal drugs.
CONCLUSIONS: Spanish patients with CD are young, have frequent hospitalization requirements, complications, and a high consumption of drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524641

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.

Authors:  Sung Hee Choi; Byung-Gyu Kim; Janet Robinson; Steve Fink; Min Yan; Michael B Sporn; Sanford D Markowitz; John J Letterio
Journal:  J Clin Invest       Date:  2014-05-16       Impact factor: 14.808

2.  Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry.

Authors:  Esther A Torres; Abdiel Cruz; Mariola Monagas; Marina Bernal; Yadira Correa; Rafael Cordero; Víctor L Carlo
Journal:  Int J Inflam       Date:  2011-12-11

3.  Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).

Authors:  Ignacio Marín-Jiménez; Cristina Saro; Verónica Díaz; Manuel Barreiro-de Acosta; María Gómez-García; Ana Gutiérrez Casbas
Journal:  Drugs Context       Date:  2018-03-06

4.  Endoscopic Management of Benign Colonic Obstruction and Pseudo-Obstruction.

Authors:  Su Jin Jeong; Jongha Park
Journal:  Clin Endosc       Date:  2019-10-24

5.  Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.

Authors:  Damián García-Olmo; Gert Van Assche; Ignacio Tagarro; Mary Carmen Diez; Marie Paule Richard; Javaria Mona Khalid; Marc van Dijk; Dimitri Bennett; Suvi R K Hokkanen; Julián Panés
Journal:  Adv Ther       Date:  2019-10-26       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.